Related Experiment Video
Updated: Aug 8, 2026
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model
Jason T McConville1, Kirk A Overhoff, Prapasri Sinswat
1College of Pharmacy, The University of Texas at Austin, Pharmaceutics PHR 4.214, 2409 W. University Avenue, Austin, Texas 78712-1074, USA. jtmcconville@mail.utexas.edu
Purpose:
The purpose of this study was to investigate the delivery of itraconazole (ITZ) particles to a murine lung model by nebulization.
Methods:
Three ITZ formulations were prepared and characterized in the dry state using contact angle, dissolution, X-ray powder diffraction, scanning electron microscopy, and Brunauer-Emmett-Teller surface area analysis. Aerodynamic particle size distributions and lung deposition studies in 14 outbred male ICR mice were performed using aqueous dispersions of all the formulations. A separate dosing uniformity study was also performed to qualify use of the chamber.
Results:
All formulations had an aggregated particle size of approximately 30 microm in diameter. Two formulations showed that 80% of the drug dissolved in less than 5 min. The remaining ITZ formulation had a slower dissolution and the lowest total emitted dose from the nebulizer used. High concentrations of ITZ were shown to be present in the mouse lung during the lung deposition study, up to 16.8 +/- 0.13 microg/g (+/- SE) were achieved. Concentrations of up to 0.76 +/- 0.03 microg/g (+/- SE) could be maintained from the single nebulized dose for at least 24 h.
Conclusion:
An effective method of targeted delivery of ITZ to the deep lung is presented that may be useful for the treatment and prevention of acute fungal infections.
